Cervical Cancer Trials
Select Clinical Trial
Protocol Number: Regeneron R2810-ONC-1676/GOG 3016 (CVP 1601)
Protocol Title: An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator's Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma
Eligibility: Women, ages 18 or older, with progression or recurrence of cervical cancer
Contact Information: (910) 715-2200
____________________________________________________________________________________________
Protocol Number: AGENUS C750-01/GOG 3028 Cervical
Protocol Title: A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (anti-PD-1) as a Monotherapy or Combination Therapy with AGEN1884 (anti-CTLA4) or with Placebo in Women with Recurrent Cervical Cancer (Second Line).
Eligibility: Patient population 18 years and older with confirmed cervical cancer that has already been treated with other therapies and your cancer has recurred or is not responding to those treatments.
Contact Information: (910) 715-2200
____________________________________________________________________________________________